California Public Employees Retirement System reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 21.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 452,662 shares of the company’s stock after selling 120,408 shares during the period. California Public Employees Retirement System owned 0.37% of Henry Schein worth $33,067,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Artisan Partners Limited Partnership grew its stake in Henry Schein by 0.9% in the second quarter. Artisan Partners Limited Partnership now owns 6,462,204 shares of the company’s stock worth $472,064,000 after purchasing an additional 55,653 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Henry Schein by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock worth $153,480,000 after buying an additional 103,384 shares during the period. Burgundy Asset Management Ltd. grew its position in shares of Henry Schein by 33.9% during the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after buying an additional 566,530 shares in the last quarter. Clarkston Capital Partners LLC increased its stake in shares of Henry Schein by 0.4% during the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock valued at $119,965,000 after buying an additional 7,345 shares during the period. Finally, Schroder Investment Management Group raised its holdings in shares of Henry Schein by 149.3% in the second quarter. Schroder Investment Management Group now owns 1,563,899 shares of the company’s stock valued at $114,243,000 after acquiring an additional 936,471 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.
Wall Street Analyst Weigh In
HSIC has been the topic of a number of research reports. Morgan Stanley raised their target price on shares of Henry Schein from $55.00 to $58.00 and gave the company an “underweight” rating in a research report on Wednesday, November 5th. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Wells Fargo & Company raised their price target on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 5th. Evercore ISI lifted their price objective on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 5th. Finally, Barrington Research set a $79.00 target price on Henry Schein and gave the stock an “outperform” rating in a report on Wednesday, November 5th. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus target price of $76.92.
Henry Schein Trading Up 1.9%
Shares of HSIC stock opened at $75.88 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.40 and a quick ratio of 0.79. The company has a market cap of $8.93 billion, a price-to-earnings ratio of 24.01, a PEG ratio of 2.28 and a beta of 0.89. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The stock has a 50 day simple moving average of $68.80 and a 200-day simple moving average of $69.50.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its earnings results on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.02% and a return on equity of 14.76%. The business had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- How to Profit From Value Investing
- Market Momentum: 3 Stocks Poised for Major Breakouts
- What is the FTSE 100 index?
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- How to Plot Fibonacci Price Inflection Levels
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
